OmniActive's Lutemax Free Lutein Receives FDA Approval for Infant Formula Nutrition
OmniActive Health Technologies (OmniActive) has recently made headlines in the health and nutrition industries with the announcement of the U.S. Food and Drug Administration's (FDA) acknowledgment of its flagship product, Lutemax Free Lutein, for use in infant formula. This important regulatory milestone not only represents a significant achievement for the company but also opens up a new category in early life nutrition, which is highly sensitive and regulated.
The official clearance from the FDA underscores the safety and quality of Lutemax Free Lutein, aligning with the increasing demand from parents and healthcare professionals for infant nutrition products that promote both visual and cognitive health. Dr. Deshanie Rai, Vice President of Global Regulatory and Advocacy at OmniActive, emphasized the importance of lutein in breast milk and its contributions to brain and eye development. "This milestone allows infant formula to be closer to breast milk, providing manufacturers with a differentiated ingredient that supports eye and brain health during critical developmental periods," she stated.
Lutein is recognized as a carotenoid that is vital for the development of the retina and brain, with research indicating its role in enhancing visual acuity and cognitive functions. Studies have shown that lutein helps protect against blue light and aids memory, attention, and processing abilities. Given that infants are unable to produce lutein naturally, it must be provided through dietary sources. This is especially true for formula-fed infants who may not receive sufficient amounts of lutein from their diet, depending on maternal intake.
Lutemax Free Lutein is produced from marigold petals, an edible flower valued for its high lutein content, and is manufactured using sustainable and non-GMO practices. The production process emphasizes traceability and safety, ensuring that parents can trust the quality of the ingredients in infant formula. Notably, the new FDA approval offers parents a viable choice in nutrition when breastfeeding is not an option or adequate.
OmniActive's commitment to research and innovation spans two decades, showcasing their dedication to providing science-backed health solutions. The company continues to promote awareness about the importance of lutein at every life stage and reinforces its collaborations with partners in early life nutrition.
The introduction of Lutemax Free Lutein into infant formula is not just a product update; it symbolizes a holistic approach to infant nutrition—one that acknowledges the critical first years of life as a time for growth and development that sets the foundation for a child’s future health. To further explore their product line and learn more about their commitment to health and nutrition, interested parties are encouraged to visit OmniActive's official website at omniactives.com.
With this new addition to baby formula, parents can be assured that they are providing their infants with the essential nutrients they need for optimum brain and eye development. As more and more families are looking to nutritionally comprehensive solutions, the approval of Lutemax Free Lutein represents a significant step forward in supporting infant well-being and development. This development not only reflects advances within the industry but also reaffirms OmniActive's position as a leader in providing innovative health solutions.
The official clearance from the FDA underscores the safety and quality of Lutemax Free Lutein, aligning with the increasing demand from parents and healthcare professionals for infant nutrition products that promote both visual and cognitive health. Dr. Deshanie Rai, Vice President of Global Regulatory and Advocacy at OmniActive, emphasized the importance of lutein in breast milk and its contributions to brain and eye development. "This milestone allows infant formula to be closer to breast milk, providing manufacturers with a differentiated ingredient that supports eye and brain health during critical developmental periods," she stated.
Lutein is recognized as a carotenoid that is vital for the development of the retina and brain, with research indicating its role in enhancing visual acuity and cognitive functions. Studies have shown that lutein helps protect against blue light and aids memory, attention, and processing abilities. Given that infants are unable to produce lutein naturally, it must be provided through dietary sources. This is especially true for formula-fed infants who may not receive sufficient amounts of lutein from their diet, depending on maternal intake.
Lutemax Free Lutein is produced from marigold petals, an edible flower valued for its high lutein content, and is manufactured using sustainable and non-GMO practices. The production process emphasizes traceability and safety, ensuring that parents can trust the quality of the ingredients in infant formula. Notably, the new FDA approval offers parents a viable choice in nutrition when breastfeeding is not an option or adequate.
OmniActive's commitment to research and innovation spans two decades, showcasing their dedication to providing science-backed health solutions. The company continues to promote awareness about the importance of lutein at every life stage and reinforces its collaborations with partners in early life nutrition.
The introduction of Lutemax Free Lutein into infant formula is not just a product update; it symbolizes a holistic approach to infant nutrition—one that acknowledges the critical first years of life as a time for growth and development that sets the foundation for a child’s future health. To further explore their product line and learn more about their commitment to health and nutrition, interested parties are encouraged to visit OmniActive's official website at omniactives.com.
With this new addition to baby formula, parents can be assured that they are providing their infants with the essential nutrients they need for optimum brain and eye development. As more and more families are looking to nutritionally comprehensive solutions, the approval of Lutemax Free Lutein represents a significant step forward in supporting infant well-being and development. This development not only reflects advances within the industry but also reaffirms OmniActive's position as a leader in providing innovative health solutions.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.